A Three-Arm, Tiered Comparability Strategy Bridging Post-Approval Process Changes for an Omalizumab Biosimilar (CMAB007).
Saved in:
| Title: | A Three-Arm, Tiered Comparability Strategy Bridging Post-Approval Process Changes for an Omalizumab Biosimilar (CMAB007). |
|---|---|
| Authors: | Wang, Chenguang1,2,3,4 (AUTHOR), Zhou, Chaoxin1,2,3,4 (AUTHOR), Hou, Sheng1,2,3,4 (AUTHOR), Fan, Wenqiang1,4 (AUTHOR), Qian, Weizhu1,2,3,4 (AUTHOR), Ren, Yule1,2,3,4 (AUTHOR), Chen, Xiyuan4 (AUTHOR), Pan, Chenhong4 (AUTHOR), Guo, Qingcheng1,2,3,4 (AUTHOR), Guo, Huaizu1,2,3 (AUTHOR), Guo, Yajun1,2,3 (AUTHOR) |
| Source: | Pharmaceuticals (14248247). May2026, Vol. 19 Issue 5, p724. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 194117548 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Three-Arm, Tiered Comparability Strategy Bridging Post-Approval Process Changes for an Omalizumab Biosimilar (CMAB007). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Wang%2C+Chenguang%22">Wang, Chenguang</searchLink><relatesTo>1,2,3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Chaoxin%22">Zhou, Chaoxin</searchLink><relatesTo>1,2,3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hou%2C+Sheng%22">Hou, Sheng</searchLink><relatesTo>1,2,3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fan%2C+Wenqiang%22">Fan, Wenqiang</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qian%2C+Weizhu%22">Qian, Weizhu</searchLink><relatesTo>1,2,3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ren%2C+Yule%22">Ren, Yule</searchLink><relatesTo>1,2,3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Xiyuan%22">Chen, Xiyuan</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pan%2C+Chenhong%22">Pan, Chenhong</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guo%2C+Qingcheng%22">Guo, Qingcheng</searchLink><relatesTo>1,2,3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guo%2C+Huaizu%22">Guo, Huaizu</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guo%2C+Yajun%22">Guo, Yajun</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Pharmaceuticals+%2814248247%29%22">Pharmaceuticals (14248247)</searchLink>. May2026, Vol. 19 Issue 5, p724. 17p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=194117548 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/ph19050724 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 17 StartPage: 724 Titles: – TitleFull: A Three-Arm, Tiered Comparability Strategy Bridging Post-Approval Process Changes for an Omalizumab Biosimilar (CMAB007). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wang, Chenguang – PersonEntity: Name: NameFull: Zhou, Chaoxin – PersonEntity: Name: NameFull: Hou, Sheng – PersonEntity: Name: NameFull: Fan, Wenqiang – PersonEntity: Name: NameFull: Qian, Weizhu – PersonEntity: Name: NameFull: Ren, Yule – PersonEntity: Name: NameFull: Chen, Xiyuan – PersonEntity: Name: NameFull: Pan, Chenhong – PersonEntity: Name: NameFull: Guo, Qingcheng – PersonEntity: Name: NameFull: Guo, Huaizu – PersonEntity: Name: NameFull: Guo, Yajun IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: May2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 14248247 Numbering: – Type: volume Value: 19 – Type: issue Value: 5 Titles: – TitleFull: Pharmaceuticals (14248247) Type: main |
| ResultId | 1 |